The F-box protein FBXW7 is the substrate-recruiting subunit of an SCF ubiquitin ligase and a major tumor-suppressor protein that is altered in several human malignancies. Loss of function of FBXW7 results in the stabilization of numerous proteins that orchestrate cell proliferation and survival. Little is known about proteins that directly regulate the function of this protein. In the current work, we have mapped the interactome of the enigmatic pseudophosphatase STYX We reasoned that a catalytically inactive phosphatase might have adopted novel mechanisms of action. The STYX interactome contained several F-box proteins, including FBXW7. We show that STYX binds to the F-box domain of FBXW7 and disables its recruitment into the SCF complex. Therefore, STYX acts as a direct inhibitor of FBXW7, affecting the cellular levels of its substrates. Furthermore, we find that levels of STYX and FBXW7 are anti-correlated in breast cancer patients, which affects disease prognosis. We propose the STYX-FBXW7 interaction as a promising drug target for future investigations.

The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function / V. Reiterer, C. Figueras Puig, F. Le Guerroue, S. Confalonieri, M. Vecchi, D. Jalapothu, S.M. Kanse, R.J. Deshaies, P.P. Di Fiore, C. Behrends, H. Farhan. - In: EMBO JOURNAL. - ISSN 0261-4189. - 36:3(2017), pp. 260-273. [10.15252/embj.201694795]

The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function

P.P. Di Fiore;
2017

Abstract

The F-box protein FBXW7 is the substrate-recruiting subunit of an SCF ubiquitin ligase and a major tumor-suppressor protein that is altered in several human malignancies. Loss of function of FBXW7 results in the stabilization of numerous proteins that orchestrate cell proliferation and survival. Little is known about proteins that directly regulate the function of this protein. In the current work, we have mapped the interactome of the enigmatic pseudophosphatase STYX We reasoned that a catalytically inactive phosphatase might have adopted novel mechanisms of action. The STYX interactome contained several F-box proteins, including FBXW7. We show that STYX binds to the F-box domain of FBXW7 and disables its recruitment into the SCF complex. Therefore, STYX acts as a direct inhibitor of FBXW7, affecting the cellular levels of its substrates. Furthermore, we find that levels of STYX and FBXW7 are anti-correlated in breast cancer patients, which affects disease prognosis. We propose the STYX-FBXW7 interaction as a promising drug target for future investigations.
breast cancer; Cullin–RING ubiquitin ligase; F-box protein; mass spectrometry; pseudophosphatase
Settore MED/04 - Patologia Generale
2017
22-dic-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
Reiterer et al.pdf

accesso riservato

Descrizione: Full article
Tipologia: Publisher's version/PDF
Dimensione 2.51 MB
Formato Adobe PDF
2.51 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/465615
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
  • OpenAlex ND
social impact